$152 Million is the total value of Iguana Healthcare Management, LLC's 62 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SPDR S&P 500 ETF TRput | $13,158,000 | – | 50,000 | +100.0% | 8.66% | – | |
| SHPG | New | SHIRE PLCsponsored adr | $3,735,000 | – | 25,000 | +100.0% | 2.46% | – |
| New | ESPERION THERAPEUTICS INC NEput | $3,617,000 | – | 50,000 | +100.0% | 2.38% | – | |
| CNC | New | CENTENE CORP DEL | $3,206,000 | – | 30,000 | +100.0% | 2.11% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $3,065,000 | – | 27,500 | +100.0% | 2.02% | – |
| LH | New | LABORATORY CORP AMER HLDGS | $2,831,000 | – | 17,500 | +100.0% | 1.86% | – |
| DXCM | New | DEXCOM INC | $2,596,000 | – | 35,000 | +100.0% | 1.71% | – |
| CBIO | New | CATALYST BIOSCIENCES INC | $2,580,000 | – | 100,000 | +100.0% | 1.70% | – |
| ZSAN | New | ZOSANO PHARMA CORP | $2,520,000 | – | 500,000 | +100.0% | 1.66% | – |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $2,344,000 | – | 125,000 | +100.0% | 1.54% | – |
| ARMO | New | ARMO BIOSCIENCES INC | $2,245,000 | – | 60,000 | +100.0% | 1.48% | – |
| New | SPDR SERIES TRUSTput | $2,193,000 | – | 25,000 | +100.0% | 1.44% | – | |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $1,690,000 | – | 100,000 | +100.0% | 1.11% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $1,689,000 | – | 55,000 | +100.0% | 1.11% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $1,442,000 | – | 200,000 | +100.0% | 0.95% | – |
| CERN | New | CERNER CORP | $1,160,000 | – | 20,000 | +100.0% | 0.76% | – |
| XNCR | New | XENCOR INC | $1,049,000 | – | 35,000 | +100.0% | 0.69% | – |
| KURA | New | KURA ONCOLOGY INC | $938,000 | – | 50,000 | +100.0% | 0.62% | – |
| SGEN | New | SEATTLE GENETICS INC | $916,000 | – | 17,500 | +100.0% | 0.60% | – |
| SPPI | New | SPECTRUM PHARMACEUTICALS INC | $805,000 | – | 50,000 | +100.0% | 0.53% | – |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $737,000 | – | 15,000 | +100.0% | 0.48% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $717,000 | – | 30,000 | +100.0% | 0.47% | – |
| EXEL | New | EXELIXIS INC | $665,000 | – | 30,000 | +100.0% | 0.44% | – |
| AFMD | New | AFFIMED N V | $555,000 | – | 300,000 | +100.0% | 0.36% | – |
| SLDB | New | SOLID BIOSCIENCES INC | $375,000 | – | 50,000 | +100.0% | 0.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.